SCHEMBL4557360

SCHEMBL4557360

CC(=O)[C@H]1CC[C@H]2[C@H]3CCC4CCCC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 5/20 0.69
GABRB2 P47870 5/20 0.69
GABRP O00591 4/20 0.69
GABRD O14764 4/20 0.69
GABRB1 P18505 4/20 0.69
GABRG2 P18507 4/20 0.69
GABRB3 P28472 4/20 0.69
GABRA5 P31644 4/20 0.69
GABRA3 P34903 4/20 0.69
GABRA2 P47869 4/20 0.69
GABRA4 P48169 4/20 0.69
GABRE P78334 4/20 0.69
GABRA6 Q16445 4/20 0.69
GABRG1 Q8N1C3 4/20 0.69
GABRG3 Q99928 4/20 0.69
GABRQ Q9UN88 4/20 0.69
AKR1B10 O60218 3/20 0.69
AKR1B1 P15121 3/20 0.69
G6PD P11413 2/20 0.69
CYP3A4 P08684 2/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12178194 1.00 GABRA1 (0.69) GABRA1GABRB2GABRPGABRDGABRB1
SCHEMBL13012758 1.00 GABRA1 (0.69) GABRA1GABRB2GABRPGABRDGABRB1
SCHEMBL7300704 1.00 GABRA1 (0.69) GABRA1GABRB2GABRPGABRDGABRB1
SCHEMBL18610325 1.00 GABRA1 (0.69) GABRA1GABRB2GABRPGABRDGABRB1
SCHEMBL22451788 1.00 GABRA1 (0.69) GABRA1GABRB2GABRPGABRDGABRB1
SCHEMBL23872369 1.00 GABRA1 (0.69) GABRA1GABRB2GABRPGABRDGABRB1
SCHEMBL598324 1.00 GABRA1 (0.69) GABRA1GABRB2GABRPGABRDGABRB1
SCHEMBL10308278 1.00 GABRA1 (0.69) GABRA1GABRB2GABRPGABRDGABRB1
SCHEMBL3049001 1.00 GABRA1 (0.69) GABRA1GABRB2GABRPGABRDGABRB1
SCHEMBL598323 1.00 GABRA1 (0.69) GABRA1GABRB2GABRPGABRDGABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009142594-A1 THE USE OF 3BETA-ETHENYL, METHYL, 3ALPHA-HYDROXY-STEROIDS FOR THE TREATMENT OF CNS DISORDERS UMECRINE AB (SE) 2009-11-26 WO disclosed